Matches in SemOpenAlex for { <https://semopenalex.org/work/W2602128654> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2602128654 abstract "Abstract Background: 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) has established a role in the evaluation of several malignancies. However, its precise clinical role in the neural crest cell tumors continues to evolve. Purpose: The purpose of this study was to compare iodine-131 metaiodobenzylguanidine (131I-MIBG) and FDG-PET of head to head in patients with neural crest tumors both qualitatively and semiquantitatively and to determine their clinical utility in disease status evaluation and further management. Materials and Methods: A total of 32 patients who had undergone 131I-MIBG and FDG-PET prospectively were evaluated and clinicopathologically grouped into three categories: neuroblastoma, pheochromocytoma, and medullary carcinoma thyroid. Results: In 18 patients of neuroblastoma, FDG PET and 131I-MIBG showed patient-specific sensitivity of 84% and 72%, respectively. The mean maximum standardized uptake value (SUVmax) of primary lesions in patients with unfavorable histology was found to be relatively higher than those with favorable histology (5.18 ± 2.38 vs. 3.21 ± 1.69). The mean SUVmaxof two common sites (posterior superior iliac spine [PSIS] and greater trochanter) was higher in patients with involved marrow than those with uninvolved one (2.36 and 2.75 vs. 1.26 and 1.34, respectively). The ratio of SUVmaxof the involved/contralateral normal sites was 2.16 ± 1.9. In equivocal bone marrow results, the uptake pattern with SUV estimation can depict metastatic involvement and help in redirecting the biopsy site. Among seven patients of pheochromocytoma, FDG-PET revealed 100% patient-specific sensitivity. FDG-PET detected more metastatic foci than 131I-MIBG (18 vs. 13 sites). In seven patients of medullary carcinoma thyroid, FDG-PET localized residual, recurrent, or metastatic disease with much higher sensitivity (32 metastatic foci with 72% patient specific sensitivity) than 131I-MIBG, trending along the higher serum calcitonin levels. Conclusions: FDG-PET is not only a good complementary modality in the management of neural crest cell tumors but also it can even be superior, especially in cases of 131I-MIBG nonavid tumors." @default.
- W2602128654 created "2017-04-07" @default.
- W2602128654 creator A5054315303 @default.
- W2602128654 creator A5065789609 @default.
- W2602128654 creator A5070523753 @default.
- W2602128654 date "2017-01-01" @default.
- W2602128654 modified "2023-09-26" @default.
- W2602128654 title "Comparative evaluation of iodine-131 metaiodobenzylguanidine and 18-fluorodeoxyglucose positron emission tomography in assessing neural crest tumors: Will they play a complementary role?" @default.
- W2602128654 cites W100330603 @default.
- W2602128654 cites W1956111485 @default.
- W2602128654 cites W2000537734 @default.
- W2602128654 cites W2016884720 @default.
- W2602128654 cites W2019137723 @default.
- W2602128654 cites W2037773575 @default.
- W2602128654 cites W2085662827 @default.
- W2602128654 cites W2094377427 @default.
- W2602128654 cites W2160759504 @default.
- W2602128654 cites W2317690033 @default.
- W2602128654 cites W2325964278 @default.
- W2602128654 doi "https://doi.org/10.4103/2278-330x.202556" @default.
- W2602128654 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5379891" @default.
- W2602128654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28413794" @default.
- W2602128654 hasPublicationYear "2017" @default.
- W2602128654 type Work @default.
- W2602128654 sameAs 2602128654 @default.
- W2602128654 citedByCount "3" @default.
- W2602128654 countsByYear W26021286542019 @default.
- W2602128654 countsByYear W26021286542021 @default.
- W2602128654 countsByYear W26021286542022 @default.
- W2602128654 crossrefType "journal-article" @default.
- W2602128654 hasAuthorship W2602128654A5054315303 @default.
- W2602128654 hasAuthorship W2602128654A5065789609 @default.
- W2602128654 hasAuthorship W2602128654A5070523753 @default.
- W2602128654 hasBestOaLocation W26021286541 @default.
- W2602128654 hasConcept C126749454 @default.
- W2602128654 hasConcept C126838900 @default.
- W2602128654 hasConcept C141071460 @default.
- W2602128654 hasConcept C142724271 @default.
- W2602128654 hasConcept C195121873 @default.
- W2602128654 hasConcept C196843134 @default.
- W2602128654 hasConcept C199374082 @default.
- W2602128654 hasConcept C2775842073 @default.
- W2602128654 hasConcept C2775934546 @default.
- W2602128654 hasConcept C2776715637 @default.
- W2602128654 hasConcept C2777415128 @default.
- W2602128654 hasConcept C2779079599 @default.
- W2602128654 hasConcept C2779512018 @default.
- W2602128654 hasConcept C2780007613 @default.
- W2602128654 hasConcept C2989005 @default.
- W2602128654 hasConcept C54355233 @default.
- W2602128654 hasConcept C57742111 @default.
- W2602128654 hasConcept C71924100 @default.
- W2602128654 hasConcept C81885089 @default.
- W2602128654 hasConcept C86803240 @default.
- W2602128654 hasConcept C95444343 @default.
- W2602128654 hasConceptScore W2602128654C126749454 @default.
- W2602128654 hasConceptScore W2602128654C126838900 @default.
- W2602128654 hasConceptScore W2602128654C141071460 @default.
- W2602128654 hasConceptScore W2602128654C142724271 @default.
- W2602128654 hasConceptScore W2602128654C195121873 @default.
- W2602128654 hasConceptScore W2602128654C196843134 @default.
- W2602128654 hasConceptScore W2602128654C199374082 @default.
- W2602128654 hasConceptScore W2602128654C2775842073 @default.
- W2602128654 hasConceptScore W2602128654C2775934546 @default.
- W2602128654 hasConceptScore W2602128654C2776715637 @default.
- W2602128654 hasConceptScore W2602128654C2777415128 @default.
- W2602128654 hasConceptScore W2602128654C2779079599 @default.
- W2602128654 hasConceptScore W2602128654C2779512018 @default.
- W2602128654 hasConceptScore W2602128654C2780007613 @default.
- W2602128654 hasConceptScore W2602128654C2989005 @default.
- W2602128654 hasConceptScore W2602128654C54355233 @default.
- W2602128654 hasConceptScore W2602128654C57742111 @default.
- W2602128654 hasConceptScore W2602128654C71924100 @default.
- W2602128654 hasConceptScore W2602128654C81885089 @default.
- W2602128654 hasConceptScore W2602128654C86803240 @default.
- W2602128654 hasConceptScore W2602128654C95444343 @default.
- W2602128654 hasLocation W26021286541 @default.
- W2602128654 hasLocation W26021286542 @default.
- W2602128654 hasLocation W26021286543 @default.
- W2602128654 hasOpenAccess W2602128654 @default.
- W2602128654 hasPrimaryLocation W26021286541 @default.
- W2602128654 hasRelatedWork W1982187894 @default.
- W2602128654 hasRelatedWork W1993571047 @default.
- W2602128654 hasRelatedWork W2035448191 @default.
- W2602128654 hasRelatedWork W2051101979 @default.
- W2602128654 hasRelatedWork W2053309800 @default.
- W2602128654 hasRelatedWork W2111347914 @default.
- W2602128654 hasRelatedWork W2124184805 @default.
- W2602128654 hasRelatedWork W2163532374 @default.
- W2602128654 hasRelatedWork W2373892949 @default.
- W2602128654 hasRelatedWork W2602128654 @default.
- W2602128654 isParatext "false" @default.
- W2602128654 isRetracted "false" @default.
- W2602128654 magId "2602128654" @default.
- W2602128654 workType "article" @default.